A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia

Jasleen K. Randhawa, Alessandra Ferrajoli

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Chronic lymphocytic leukemia (CLL) is the most prevalent type of adult leukemia encountered in the western world. Patients with CLL are typically older, with a median age in the 70s, and are at risk for certain complications due to the disease itself and due to the therapies imparted for this. Patients with CLL are at a higher risk of infections, partly due to disease and partly due to the immune dysfunction induced by treatment, such as purine analogous-based chemoimmunotherapy, which leads to lymphocyte depletion. Infections are a leading cause of complications and death in CLL patients. Also, CLL patients have been shown to have a higher incidence of other malignancies. Despite this knowledge, there are no definite guidelines as to what is the best approach to manage or prevent these associated complications of CLL. In this review, the authors discuss the data available and outline recommendations as to the best way to approach this issue in daily practice.

Original languageEnglish (US)
Pages (from-to)235-244
Number of pages10
JournalExpert Review of Hematology
Volume9
Issue number3
DOIs
StatePublished - Mar 3 2016

Keywords

  • Cancer screening
  • Chronic lymphocytic leukemia
  • Infection prophylaxis
  • Infectious complications
  • Second cancers

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Cite this